产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
BRN3A分子别名
POU domain; class 4; transcription factor 1; Brain-specific homeobox/POU domain protein 3A (Brain-3A; Brn-3A); Homeobox/POU domain protein RDC-1; Oct-T1; RDC1; POU4F1免疫原
Synthetic Peptide细胞定位
Nucleus, CytoplasmAccession
Q01851克隆号
S-1867-5抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Ms, Rt预测反应种属
(反应种属缩写表)Ck纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 WB 1:10000 Ms, Rt
BRN3A, also known as POU4F1, is a multifunctional transcription factor belonging to the POU family of transcription factors. It plays a crucial role in the differentiation and survival of specific neuronal lineages, particularly in sensory neurons and brainstem nuclei involved in motor control. BRN3A regulates gene expression by binding to the consensus octamer motif in the regulatory regions of target genes, with its C-terminal domain mediating DNA binding and its N-terminal domain contributing to transcriptional activation. It is highly expressed during embryonic development, particularly in the brain, spinal cord, and retina, and is essential for the specification and survival of retinal ganglion cells. Additionally, BRN3A has been implicated in protecting neurons from apoptosis by activating BCL2 expression and is involved in the regulation of synaptic protein expression.
免疫印迹
WB result of BRN3A Recombinant Rabbit mAb
Primary antibody: BRN3A Recombinant Rabbit mAb at 1/10000 dilution
Lane 1: mouse brain lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 43 kDa
Observed MW: 50 kDaWB result of BRN3A Recombinant Rabbit mAb
Primary antibody: BRN3A Recombinant Rabbit mAb at 1/10000 dilution
Lane 1: C6 whole cell lysate 20 µg
Lane 2: rat brain lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 43 kDa
Observed MW: 50 kDa
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定







评论(0)